A patient with simultaneous absence of "classical" natural killer cells (CD3-, CD16+, and NKH1+) and expansion of CD3+, CD4-, CD8-, NKH1+ subset.
about
Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasiaLicensed and Unlicensed NK Cells: Differential Roles in Cancer and Viral ControlDeficient natural killer cell cytotoxicity in patients with IKK-gamma/NEMO mutations.Accessory cell dependent NK cell mediated PBMC IFN-gamma production is defective in HIV infection.Brominated flame retardants, tetrabromobisphenol A and hexabromocyclododecane, activate mitogen-activated protein kinases (MAPKs) in human natural killer cellsArrested natural killer cell development associated with transgene insertion into the Atf2 locusSevere viral infections and primary immunodeficiencies.Haematopoietic and immune defects associated with GATA2 mutation.Partial MCM4 deficiency in patients with growth retardation, adrenal insufficiency, and natural killer cell deficiency.Reciprocal age related change in natural killer cell receptors for MHC class I.Pentachlorophenol decreases tumor-cell-binding capacity and cell-surface protein expression of human natural killer cells.Effects of DDT and triclosan on tumor-cell binding capacity and cell-surface protein expression of human natural killer cells.Tributyltin and dibutyltin alter secretion of tumor necrosis factor alpha from human natural killer cells and a mixture of T cells and natural killer cellsMutations in GATA2 cause human NK cell deficiency with specific loss of the CD56(bright) subset.Defective expression of p56lck in an infant with severe combined immunodeficiency.Natural killer cell deficiency.Primary immunodeficiency diseases: relevant aspects for pulmonologists.CpG DNA induces cyclooxygenase-2 expression and prostaglandin production.Impaired plasmacytoid dendritic cell (PDC)-NK cell activity in viremic human immunodeficiency virus infection attributable to impairments in both PDC and NK cell function.A Tumor Profile in Primary Immune Deficiencies Challenges the Cancer Immune Surveillance Concept.Natural Killer (NK) cell deficiency associated with an epitope-deficient Fc receptor type IIIA (CD16-II)
P2860
Q24634431-2C0AAB41-9560-4B7C-8F11-F0695AB4D0A4Q26747397-3DCD74C0-83D0-4ED5-84EC-5070C3EC46ABQ30453097-3AF923AF-9300-43B8-AC10-4BC724313FACQ34020126-D3C0BB50-0768-4CB0-A675-443E2FB4862CQ34580183-44D970FE-1217-495E-B2D0-DDA9BD1C5D71Q34595021-78D3381B-3DCE-42C1-B29C-904B997F522AQ35290347-735F46F7-AACB-4B77-8150-103797D1BE26Q35535835-A4166268-3DCB-49F5-B6DC-9775361253AEQ35780304-9990FEBC-29D8-42CB-B962-0C193820578AQ36088741-D0B01448-6064-418F-99A9-899D7E618371Q36192843-FFFA2952-1D4D-4686-9C55-666E1E3F95BEQ36282216-78DFA766-6349-4E6E-AC2C-C53221BEA82FQ36605357-7936943A-B74A-4223-8841-AEFEA4B85767Q36743341-255AE512-0CB6-474F-9567-151EF0B69A18Q37383981-45BA2F5F-31C0-4C14-A04A-ADA9EBB90943Q37567421-67F66EAC-D470-447A-BC3A-2D7A358892F6Q37634016-FAB34448-B0D3-4325-816E-6B52743F067DQ40790193-14DB3613-3968-4BC1-8369-534161A4EE0FQ42614451-70C53162-C06B-47B2-AC70-E72F35C23DFAQ55004131-255DBE35-B970-4403-A9DB-149200666A9BQ55670943-814D12A1-8504-4B0D-AEAC-78B2C26BD872
P2860
A patient with simultaneous absence of "classical" natural killer cells (CD3-, CD16+, and NKH1+) and expansion of CD3+, CD4-, CD8-, NKH1+ subset.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh-hant
name
A patient with simultaneous ab ...... D3+, CD4-, CD8-, NKH1+ subset.
@en
A patient with simultaneous ab ...... D3+, CD4-, CD8-, NKH1+ subset.
@nl
type
label
A patient with simultaneous ab ...... D3+, CD4-, CD8-, NKH1+ subset.
@en
A patient with simultaneous ab ...... D3+, CD4-, CD8-, NKH1+ subset.
@nl
prefLabel
A patient with simultaneous ab ...... D3+, CD4-, CD8-, NKH1+ subset.
@en
A patient with simultaneous ab ...... D3+, CD4-, CD8-, NKH1+ subset.
@nl
P2093
P1476
A patient with simultaneous ab ...... CD3+, CD4-, CD8-, NKH1+ subset
@en
P2093
D A Turner
E A Goetzman
J M Turner
P304
P356
10.1016/0091-6749(90)90155-W
P407
P577
1990-02-01T00:00:00Z